{
    "Trade/Device Name(s)": [
        "Quantisal Oral Fluid Collection Device"
    ],
    "Submitter Information": "Immunalysis Corporation",
    "510(k) Number": "K232898",
    "Predicate Device Reference 510(k) Number(s)": [
        "K200801"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "PJD"
    ],
    "Summary Letter Date": "September 18, 2023",
    "Summary Letter Received Date": "September 18, 2023",
    "Submission Date": "November 3, 2023",
    "Regulation Number(s)": [
        "21 CFR 862.1675"
    ],
    "Regulation Name(s)": [
        "Blood Specimen Collection Device"
    ],
    "Analyte Class(es)": [
        "toxicology"
    ],
    "Analyte(s)": [
        "THC",
        "Benzoylecgonine",
        "Cocaine",
        "Morphine",
        "Codeine",
        "Oxycodone",
        "Hydrocodone",
        "6-acetylmorphine",
        "Phencyclidine",
        "Amphetamine",
        "Methamphetamine",
        "Buprenorphine",
        "Methadone",
        "Benzodiazepines",
        "Tramadol"
    ],
    "Specimen Type(s)": [
        "Oral fluid"
    ],
    "Specimen Container(s)": [
        "Polypropylene tube with preservative buffer"
    ],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Liquid chromatography-tandem mass spectrometry (LC-MS/MS)",
        "Gas chromatography\u2013mass spectrometry (GC-MS)"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "Specimen collection device",
        "Transport medium"
    ],
    "Document Summary": "FDA 510(k) summary for Quantisal Oral Fluid Collection Device for collection, preservation, and transport of oral fluid specimens for drugs of abuse testing",
    "Indications for Use Summary": "Intended for the collection, preservation, and transport of oral fluid specimens for drugs of abuse testing; for prescription use only.",
    "fda_folder": "Clinical Chemistry"
}